Results 101 to 110 of about 2,912 (149)

[Comparison of antiviral efficacy of nucleos(t)ide analogue monotherapy and its combination with interferon-α in children 1-6 years-old with HBeAg-positive chronic hepatitis B]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wang ZW, Dong Y, Ouyang WX, Cao LL, Pang L, Xu HM, Yan JG, Zhu Y, Xu Y, Fu JL, Wang FS, Zhang M.   +11 more
europepmc   +1 more source

[Reflections on the novel definition and whether or not antiviral therapy for inactive HBsAg carrier state in the "Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)"]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Ren S, Zheng SJ, Chen XY.
europepmc   +1 more source

[Analysis of antiviral efficacy in pediatric patients with HBeAg-negative chronic hepatitis B]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Guo X, Fan PY, Li J, Wang LX, Dong Y, Cao LL, Yan JG, Zhang M, Wang FS.   +8 more
europepmc   +1 more source

恩替卡韦联合糖皮质激素治疗乙肝病毒相关性肾炎的临床观察

Linchuang shenzangbing zazhi, 2013
目的 观察恩替卡韦联合糖皮质激素治疗乙型肝炎(乙肝)病毒相关性肾炎的临床效果。方法 选取在我完住院的乙肝病毒相关性肾炎患者65例,将患者随机分成2组。单一抗病毒组30例,单用恩替卡韦抗病毒治疗。联合治疗组35例,恩替卡韦抗病毒联合适量、短期糖皮质激素治疗。2组均给予常规护肝、降酶及保护肾功能治疗。对所有患者治疗前、后乙肝病毒DNA、肝功能、肾功能、血尿常规进行测定。结果 在抗病毒、护肝方面,治疗12个月后,2组血清乙肝病毒DNA载量及丙氨酸氨基转移酶、天冬氨酸氨基转移酶水平下降幅度均无明显差异 ...
doaj  

[Advances in clinical features, diagnosis, and treatment of pre-acute-on-chronic liver failure]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Nie YH, Cai DC.
europepmc   +1 more source

慢性丙型肝炎患者并糖尿病的危险因素分析

Zhongshan Daxue xuebao. Yixue kexue ban, 2013
【目的】 探讨慢性丙型肝炎(CHC)与糖尿病(DM)的关系及其相关因素?【方法】 对200例CHC并DM患者(CHC+DM组)与242例CHC不合并DM患者(CHC组)的谷丙转氨酶(ALT)?谷草转氨酶(AST)?γ-谷氨酰转肽酶(GGT)?总胆红素(TB)?空腹血糖?空腹胰岛素?血甘油三酯及血清丙型肝炎病毒(HCV)RNA等相关指标进行检测?分析,比较两组之间各指标的差异,并将CHC+DM组分为携带者?轻度?中度?重度及不同年龄段进行对照比较,探讨CHC易发生DM的相关因素?【结果】 ①CHC ...
doaj  

[Expert consensus on the management process within medical institutions for patients with hepatitis B virus infection]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Author Group of Expert Consensus.
europepmc   +1 more source

[The partial cure represents an intermediate endpoint on the path to a functional cure, not an ideal endpoint]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zhuang H.
europepmc   +1 more source

[<i>Yiqi Jiedu</i> Formula regulates immune microenvironment of liver cancer in mice by inhibiting overactivation of NF-κB signaling pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Wang Z, Liu L, Shi M, Hou Y, Dong L, Zhang G.   +5 more
europepmc   +1 more source

[Analysis of the prevalence status and clinical characteristics of the hepatitis D virus in the Xinjiang region]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wang ZG, Wu X, Dou J, Guo F, Ning ZH, Zhang R, Jieensinue S, Abulimiti L, Xu Q, Wang XB, Wang HF, Abulajiang A, Zeng BF, Yang L, Wang XZ.   +14 more
europepmc   +1 more source